发明申请
US20110152326A1 SUBSTITUTED ARYLOXOETHYL CYCLOPROPANECARBOXAMIDE COMPOUNDS AS VR1 RECEPTOR ANTAGONISTS
审中-公开
作为VR1受体拮抗剂的取代的芳基乙氧基环丙酰氧基化合物
- 专利标题： SUBSTITUTED ARYLOXOETHYL CYCLOPROPANECARBOXAMIDE COMPOUNDS AS VR1 RECEPTOR ANTAGONISTS
- 专利标题（中）： 作为VR1受体拮抗剂的取代的芳基乙氧基环丙酰氧基化合物
-
申请号： US11909843申请日： 2006-03-15
-
公开(公告)号： US20110152326A1公开(公告)日： 2011-06-23
- 发明人: Takeshi Hanazawa , Satoshi Nagayama , Kazumari Nakao , Hirotaka Tanaka
- 申请人： Takeshi Hanazawa , Satoshi Nagayama , Kazumari Nakao , Hirotaka Tanaka
- 国际申请： PCT/IB2006/000585 WO 20060315
- 主分类号： A61K31/44
- IPC分类号： A61K31/44 ; C07D211/70 ; C07C233/61 ; C07D233/22 ; A61K31/165 ; A61K31/4164 ; A61P9/10 ; A61P25/00 ; A61P29/00 ; A61P25/06 ; A61P13/10 ; A61P25/28 ; A61P11/00 ; A61P11/06 ; A61P1/00 ; A61P3/04
摘要：
This invention provides a compound of the formula (I): (I) These compounds are useful for the treatment of disease conditions caused by overactivation of the VR1 receptor, such as pain, or the like in mammalian. This invention also provides a pharmaceutical composition comprising the above compound.